tirzepatide diuretic Peeing a Lot on Tirzepatide:

Rare serious risks include pancreatitis or thyroid concerns

Kumar et al., 2023)

Key considerations in UK practice include: Cancer cure status TRT is generally only considered after curative treatment with no evidence of disease recurrence Time since treatment Expert opinion typically suggests waiting at least 1224 months post-treatment before considering TRT [5] [11] Prostate-specific antigen (PSA) levels Stable, undetectable or very low PSA levels are typically required (measured in g/L in the UK) Cancer characteristics Low-risk, organ-confined disease with favourable pathology is preferred The European Association of Urology (EAU) guidelines, which influence UK practice, state that TRT may be considered in selected patients with low-risk prostate cancer who have been successfully treated, though they emphasise the need for careful patient selection and monitoring

Ketogenic diet suppresses colorectal cancer through the gut microbiome long chain fatty acid stearate